Long-Term Levels of LDL-C and Cognitive Function: The CARDIA Study.
Cholesterol
Cognition
Cohort studies
LDL
Lipids
Journal
Journal of the International Neuropsychological Society : JINS
ISSN: 1469-7661
Titre abrégé: J Int Neuropsychol Soc
Pays: England
ID NLM: 9503760
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
pubmed:
11
2
2021
medline:
23
11
2021
entrez:
10
2
2021
Statut:
ppublish
Résumé
It is uncertain if long-term levels of low-density lipoprotein-cholesterol (LDL-C) affect cognition in middle age. We examined the association of LDL-C levels over 25 years with cognitive function in a prospective cohort of black and white US adults. Lipids were measured at baseline (1985-1986; age: 18-30 years) and at serial examinations conducted over 25 years. Time-averaged cumulative LDL-C was calculated using the area under the curve for 3,328 participants with ≥3 LDL-C measurements and a cognitive function assessment. Cognitive function was assessed at the Year 25 examination with the Digit Symbol Substitution Test [DSST], Rey Auditory Visual Learning Test [RAVLT], and Stroop Test. A brain magnetic resonance imaging (MRI) sub-study (N = 707) was also completed at Year 25 to assess abnormal white matter tissue volume (AWMV) and gray matter cerebral blood flow volume (GM-CBFV) as secondary outcomes. There were 15.6%, 32.9%, 28.9%, and 22.6% participants with time-averaged cumulative LDL-C <100 mg/dL, 101-129 mg/dL, 130-159 mg/dL, and ≥160 mg/dL, respectively. Standardized differences in all cognitive function test scores ranged from 0.16 SD lower to 0.09 SD higher across time-averaged LDL-C categories in comparison to those with LDL-C < 100 mg/dL. After covariate adjustment, participants with higher versus lower time-averaged LDL-C had a lower RAVLT score (p-trend = 0.02) but no differences were present for DSST, Stroop Test, AWMV, or GM-CBFV. Cumulative LDL-C was associated with small differences in memory, as assessed by RAVLT scores, but not other cognitive or brain MRI measures over 25 years of follow-up.
Identifiants
pubmed: 33563358
pii: S1355617721000059
doi: 10.1017/S1355617721000059
pmc: PMC8353005
mid: NIHMS1662616
doi:
Substances chimiques
Cholesterol, LDL
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1048-1057Subventions
Organisme : NHLBI NIH HHS
ID : HHSN268201300026C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800004I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201300025C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800003I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800007I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800005I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800006I
Pays : United States
Références
J Am Heart Assoc. 2017 May 18;6(5):
pubmed: 28522676
Neuropsychology. 2000 Apr;14(2):224-32
pubmed: 10791862
N Engl J Med. 2017 Aug 17;377(7):633-643
pubmed: 28813214
Neurology. 2015 Jun 9;84(23):2347-53
pubmed: 25957331
Lancet Neurol. 2010 Jan;9(1):119-28
pubmed: 20083042
Hum Brain Mapp. 2013 Aug;34(8):1826-41
pubmed: 22438182
Soc Psychiatry Psychiatr Epidemiol. 2005 Jul;40(7):557-63
pubmed: 16021346
Tohoku J Exp Med. 2004 Dec;204(4):299-308
pubmed: 15572855
J Am Coll Cardiol. 2017 Feb 7;69(5):471-482
pubmed: 28153102
N Engl J Med. 2015 Apr 16;372(16):1500-9
pubmed: 25773607
J Clin Exp Neuropsychol. 2012;34(2):220-5
pubmed: 22149630
Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):e38-e81
pubmed: 30580575
Clin Chem. 2005 Jan;51(1):125-31
pubmed: 15514100
Circulation. 2014 Apr 15;129(15):1560-7
pubmed: 24687777
Lancet. 2012 Aug 11;380(9841):581-90
pubmed: 22607822
N Engl J Med. 2015 Apr 16;372(16):1489-99
pubmed: 25773378
Circulation. 2018 Mar 20;137(12):1260-1269
pubmed: 29146683
Curr Med Res Opin. 2005;21 Suppl 6:S9-16
pubmed: 16138936
Clin Chem. 1994 Jan;40(1):11-3
pubmed: 8287516
Clin Infect Dis. 2016 Oct 15;63(8):1130-1139
pubmed: 27448678
JAMA. 2007 Sep 19;298(11):1300-11
pubmed: 17878422
Drug Saf. 2015 Jun;38(6):519-26
pubmed: 25989944
Neurosci Biobehav Rev. 2010 Jul;34(8):1366-79
pubmed: 20470821
JAMA. 2013 Nov 20;310(19):2061-8
pubmed: 24240933
J Int Neuropsychol Soc. 2020 Mar;26(3):251-262
pubmed: 31543086
Am J Public Health. 2007 Apr;97(4):703-9
pubmed: 17329668
Biochim Biophys Acta. 2012 Mar;1822(3):361-9
pubmed: 21889590
Circulation. 2020 Mar 3;141(9):e139-e596
pubmed: 31992061
Am J Geriatr Psychiatry. 2008 Sep;16(9):781-5
pubmed: 18757771
Lancet. 2002 Jul 6;360(9326):7-22
pubmed: 12114036
Lancet. 2002 Nov 23;360(9346):1623-30
pubmed: 12457784
Mol Aspects Med. 2009 Jun;30(3):171-9
pubmed: 19248803
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Nat Genet. 2019 Mar;51(3):414-430
pubmed: 30820047
J Cardiopulm Rehabil. 1989 Nov;9(11):448-459
pubmed: 29657358
Arch Neurol. 2011 Nov;68(11):1385-92
pubmed: 22084122
PLoS One. 2013 May 22;8(5):e65228
pubmed: 23717695
J Am Coll Cardiol. 2020 May 12;75(18):2283-2293
pubmed: 32381158
Ann Intern Med. 2010 Aug 3;153(3):137-46
pubmed: 20679558
JAMA Intern Med. 2014 Mar;174(3):324-33
pubmed: 24493100
Dement Geriatr Cogn Disord. 2010;29(3):240-7
pubmed: 20375504
PLoS One. 2015 Mar 26;10(3):e0122138
pubmed: 25812012
BMJ. 2017 Apr 24;357:j1648
pubmed: 28438747
Arch Neurol. 2004 May;61(5):705-14
pubmed: 15148148
Curr Atheroscler Rep. 2013 Mar;15(3):307
pubmed: 23328907
Circulation. 1997 Nov 18;96(10):3287-93
pubmed: 9396418
Age (Dordr). 2014;36(4):9673
pubmed: 25073452
Methods Mol Med. 2005;108:159-72
pubmed: 16028683
Neurology. 2011 Aug 2;77(5):461-8
pubmed: 21810696
Mol Psychiatry. 2012 Mar;17(3):315-24
pubmed: 21263443